# Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis

> **NCT00604955** · PHASE4 · COMPLETED · sponsor: **PATH** · enrollment: 2000 (actual)

## Conditions studied

- Visceral Leishmaniasis

## Interventions

- **DRUG:** Paromomycin sulfate

## Key facts

- **NCT ID:** NCT00604955
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-12
- **Final completion:** 2010-01
- **Target enrollment:** 2000 (ACTUAL)
- **Last updated:** 2014-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00604955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00604955, "Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00604955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*